Overview

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of atomoxetine in reducing symptoms of depression in people with Parkinson's disease.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Atomoxetine Hydrochloride